Clinical Trial Results:
A Double-Blind, Randomised, Placebo-Controlled, Two-Phase Study (a Single Ascending Dose Phase Followed by a Proof of Concept Phase) to Assess the Safety, Efficacy and Pharmacokinetics of FX005 (50:50 PLGA) Microspheres for the Treatment of Pain in Osteoarthritis of the Knee.
Summary
|
|
EudraCT number |
2010-022976-29 |
Trial protocol |
GB AT |
Global completion date |
07 Mar 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Apr 2020
|
First version publication date |
15 Apr 2020
|
Other versions |
|
Summary report(s) |
FX005-2010-001-CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.